Scientists comment on topline results from a phase III clinical trial of the hormone receptor agonist Retatrutide. Prof Graham … read more
A randomised controlled trial published in Nature Medicine looks at the use of Orforflipron for maintenance of body weight reduction. … read more
A study published in Nature Medicine looks at an association between GLP-1 use and breast cancer survival and recurrence. Dr Mangesh … read more
A randomised controlled trial published in The Lancet looks at the use of semaglutide in patients with alcohol use disorder and comorbid … read more
A study published in Nature Medicine looks at a new tool (OBSCORE) to prioritise individuals at high risk of obesity-related complications for … read more
A randomised controlled trial published in JAMA Psychiatry looks at semaglutide use and motivation in depression. Prof Ciara McCabe, Professor of … read more
A study published in Nature looks at genetic predictors of GLP-1 medication weight loss and side effects. Dr Marie Spreckley, Research … read more
Experts comment on draft NICE guidance that recommends semaglutide to reduce the risk of heart attacks and strokes. Prof … read more
experts comment on an observational study on GLP-1 receptor agonists and lower risk of worsening mental illness Prof … read more
A cohort study published in The BMJ looks at GLP-1 use and the risk of substance use among US veterans with type … read more
A meta-analysis published in eClinicalMedicine looks at weight regain trajectories after stopping GLP-1 receptor agonist medication. Dr Adam Collins, Associate … read more
A study in rodent cells published in Nature Communications looks at GLP-1 peptides and heart vessel damage. Prof Bryan Williams, … read more
Trial results published in The Lancet looks at the efficacy and safety of a once daily-daily oral pill (Orforglipron) compared to semaglutide. … read more
What happens to body weight and measures of cardiometabolic health after people stop taking obesity drugs? A new systematic review … read more
A systematic review and meta-analysis published in the BMJ looks at weight regain after stopping obesity drugs. Prof Jason … read more
Scientists comment on new WHO guidelines for GLP-1 medications for the treatment of obesity, published by JAMA. Dr Marie Spreckley, … read more
Scientists respond to article published in Nature Medicine exploring the link between weight-loss drugs and food cravings. Dr Simon Cork, Senior … read more
A study published in the Lancet looks at semaglutide and cardiovascular health regardless of weight loss. Dr Sonya Babu-Narayan, Clinical Director, … read more
An unpublished conference abstract presented at the European Association for the Study of Diabetes (EASD) looks at a new RNA-based weight … read more
A study published in JAMA Pediatrics looks at the safety of weight loss drugs in children and adolescents with obesity or type … read more
